ASCO 2026: FDA-Cleared AI Put to the Test Multimodal AI platform goes head-to-head with a standard breast cancer assay using routine pathology image June 3, 2026 3 min The Pathologist Share Summary Takeaways Listen Insight Report Quiz Poll Top Institutions Topic Commentary
